New patent for On Target drug CYTALUX

February 4, 2022 Comments Off Posted in: Patent Added

Annual Drug Patent Expirations for CYTALUX Cytalux is a drug marketed by On Target Labs and is included in one NDA. The generic ingredient in CYTALUX is pafolacianine sodium. Additional…

The post New patent for On Target drug CYTALUX appeared first on DrugPatentWatch - Make Better Decisions.

Comments are closed.